Exploring the use of a co-formulated pharmacological chaperone AT2220 with recombinant human acid alpha-glucosidase for Pompe disease
Keyword(s):
Keyword(s):
2018 ◽
Vol 495
(4)
◽
pp. 2418-2424
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):